Devastating the Supply Wagons: Multifaceted Liposomes Capable of Exhausting Tumor to Death via Triple Energy Depletion
Tian-Yu Wang
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorXiao-Yu Zhu
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorHao-Ran Jia
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorYa-Xuan Zhu
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorYong-Xi Zhou
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorYan-Hong Li
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorCheng-Zhe Gao
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorGuang-Yu Pan
School of Intelligent Medicine and Biotechnology, Guilin Medical University, Guilin, 541100 P. R. China
Search for more papers by this authorCorresponding Author
Fu-Gen Wu
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
E-mail: [email protected]
Search for more papers by this authorTian-Yu Wang
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorXiao-Yu Zhu
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorHao-Ran Jia
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorYa-Xuan Zhu
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorYong-Xi Zhou
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorYan-Hong Li
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorCheng-Zhe Gao
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
Search for more papers by this authorGuang-Yu Pan
School of Intelligent Medicine and Biotechnology, Guilin Medical University, Guilin, 541100 P. R. China
Search for more papers by this authorCorresponding Author
Fu-Gen Wu
State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189 P. R. China
E-mail: [email protected]
Search for more papers by this authorAbstract
The anabolism of tumor cells can not only support their proliferation, but also endow them with a steady influx of exogenous nutrients. Therefore, consuming metabolic substrates or limiting access to energy supply can be an effective strategy to impede tumor growth. Herein, a novel treatment paradigm of starving-like therapy—triple energy-depleting therapy—is illustrated by glucose oxidase (GOx)/dc-IR825/sorafenib liposomes (termed GISLs), and such a triple energy-depleting therapy exhibits a more effective tumor-killing effect than conventional starvation therapy that only cuts off one of the energy supplies. Specifically, GOx can continuously consume glucose and generate toxic H2O2 in the tumor microenvironment (including tumor cells). After endocytosis, dc-IR825 (a near-infrared cyanine dye) can precisely target mitochondria and exert photodynamic and photothermal activities upon laser irradiation to destroy mitochondria. The anti-angiogenesis effect of sorafenib can further block energy and nutrition supply from blood. This work exemplifies a facile and safe method to exhaust the energy in a tumor from three aspects and starve the tumor to death and also highlights the importance of energy depletion in tumor treatment. It is hoped that this work will inspire the development of more advanced platforms that can combine multiple energy depletion therapies to realize more effective tumor treatment.
Conflict of Interest
The authors declare no conflict of interest.
Open Research
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Supporting Information
| Filename | Description |
|---|---|
| smll202308861-sup-0001-SuppMat.pdf940.2 KB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1D. Dolmans, D. Fukumura, R. K. Jain, Nat. Rev. Cancer 2003, 3, 380.
- 2A. P. Castano, P. Mroz, M. R. Hamblin, Nat. Rev. Cancer 2006, 6, 535.
- 3Y. X. Zhu, H. R. Jia, Q. Y. Duan, X. Liu, J. Yang, Y. Liu, F. G. Wu, ACS Appl. Mater. Interfaces 2020, 12, 36882.
- 4Y. H. Li, H. R. Jia, H. Y. Wang, X. W. Hua, Y. W. Bao, F. G. Wu, J. Controlled Release 2022, 351, 692.
- 5Y. Liu, P. Bhattarai, Z. Dai, X. Chen, Chem. Soc. Rev. 2019, 48, 2053.
- 6X. Yi, Q. Y. Duan, F. G. Wu, Research 2021, 2021, 9816594.
- 7H. R. Jia, Y. X. Zhu, X. Liu, G. Y. Pan, G. Gao, W. Sun, X. Zhang, Y. W. Jiang, F. G. Wu, ACS Nano 2019, 13, 11781.
- 8Y. Zhu, Q. Li, C. Wang, Y. Hao, N. Yang, M. Chen, J. Ji, L. Feng, Z. Liu, Chem. Rev. 2023, 123, 7326.
- 9G. Gao, Y. W. Jiang, Y. Guo, H. R. Jia, X. Cheng, Y. Deng, X. W. Yu, Y. X. Zhu, H. Y. Guo, W. Sun, X. Liu, J. Zhao, S. Yang, Z. W. Yu, F. M. S. Raya, G. Liang, F. G. Wu, Adv. Funct. Mater. 2020, 30, 1909391.
- 10Z. Tang, Y. Liu, M. He, W. Bu, Angew. Chem., Int. Ed. 2019, 58, 946.
- 11Z. Tang, P. Zhao, H. Wang, Y. Liu, W. Bu, Chem. Rev. 2021, 121, 1981.
- 12C. Jia, Y. Guo, F. G. Wu, Small 2022, 18, 2103868.
- 13W. Sang, Z. Zhang, Y. Dai, X. Chen, Chem. Soc. Rev. 2019, 48, 3771.
- 14X. Y. Zhu, T. Y. Wang, H. R. Jia, F. G. Wu, Adv. Funct. Mater. 2022, 32, 2207181.
- 15S. Guo, D. S. Kohane, Chem 2017, 2, 162.
- 16S. Yu, Z. Chen, X. Zeng, X. Chen, Z. Gu, Theranostics 2019, 9, 8026.
- 17L. H. Fu, C. Qi, J. Lin, P. Huang, Chem. Soc. Rev. 2018, 47, 6454.
- 18E. M. Selwan, B. T. Finicle, S. M. Kim, A. L. Edinger, FEBS Lett. 2016, 590, 885.
- 19L. H. Fu, C. Qi, Y. R. Hu, J. Lin, P. Huang, Adv. Mater. 2019, 31, 1808325.
- 20W. Fan, N. Lu, P. Huang, Y. Liu, Z. Yang, S. Wang, G. Yu, Y. Liu, J. Hu, Q. He, J. Qu, T. Wang, X. Chen, Angew. Chem., Int. Ed. 2017, 56, 1229.
- 21Y. P. Xiao, P. H. Chen, S. Lei, F. Bai, L. H. Fu, J. Lin, P. Huang, Angew. Chem., Int. Ed. 2022, 61, e202204584.
- 22Y. Zhang, S. Jiang, J. Lin, P. Huang, Angew. Chem., Int. Ed. 2022, 61, 202208583.
- 23T. He, H. Xu, Y. Zhang, S. Yi, R. Cui, S. Xing, C. Wei, J. Lin, P. Huang, Theranostics 2020, 10, 1544.
- 24S. B. Bankar, M. V. Bule, R. S. Singhal, L. Ananthanarayan, Biotechnol. Adv. 2009, 27, 489.
- 25P. Carmeliet, R. K. Jain, Nature 2000, 407, 249.
- 26G. Eelen, P. de Zeeuw, M. Simons, P. Carmeliet, Circ. Res. 2015, 116, 1231.
- 27J. Folkman, Nat. Med. 1995, 1, 27.
- 28S. Rafii, D. Lyden, R. Benezra, K. Hattori, B. Heissig, Nat. Rev. Cancer 2002, 2, 826.
- 29F. Shojaei, Cancer Lett. 2012, 320, 130.
- 30G. M. Tozer, C. Kanthou, B. C. Baguley, Nat. Rev. Cancer 2005, 5, 423.
- 31W. H. Lin, S. H. Yeh, K. H. Yeh, K. W. Chen, Y. W. Cheng, T. H. Su, P. Jao, L. C. Ni, P. J. Chen, D. S. Chen, Proc. Natl. Acad. Sci. U. S. A. 2016, 113, 11937.
- 32P. Carmeliet, R. K. Jain, Nature 2011, 473, 298.
- 33M. M. Cooney, W. van Heeckeren, S. Bhakta, J. Ortiz, S. C. Remick, Nat Clin. Pract. Oncol. 2006, 3, 682.
- 34Z. Wei, P. Liang, J. Xie, C. Song, C. Tang, Y. Wang, X. Yin, Y. Cai, W. Han, X. Dong, Chem. Sci. 2019, 10, 2778.
- 35R. Lin, J. Huang, L. Wang, Y. Li, M. Lipowska, H. Wu, J. Yang, H. Mao, Biomater. Sci. 2018, 6, 1517.
- 36J. Zhang, J. Li, Z. Shi, Y. Yang, X. Xie, S. M. Y. Lee, Y. Wang, K. W. Leong, M. Chen, Acta Biomater. 2017, 58, 349.
- 37H. Sui, J. Zhao, L. Zhou, H. Wen, W. Deng, C. Li, Y. Feng, N. Chai, Q. Zhang, J. Cai, Q. Li, Cancer Lett. 2017, 403, 86.
- 38J. S. Modica-Napolitano, K. K. Singh, Mitochondrion 2004, 4, 755.
- 39A. Mayevsky, Mitochondrion 2009, 9, 165.
- 40S. E. Weinberg, N. S. Chandel, Nat. Chem. Biol. 2014, 11, 9.
- 41D. C. Wallace, Nat. Rev. Cancer 2012, 12, 685.
- 42G. Y. Pan, H. R. Jia, Y. X. Zhu, R. H. Wang, F. G. Wu, Z. Chen, ACS Biomater. Sci. Eng. 2017, 3, 3596.
- 43G. Gao, Y. W. Jiang, W. Sun, Y. Guo, H. R. Jia, X. W. Yu, G. Y. Pan, F. G. Wu, Small 2019, 15, 1900501.
- 44Y. X. Zhu, H. R. Jia, G. Gao, G. Y. Pan, Y. W. Jiang, P. Li, N. Zhou, C. Li, C. She, N. W. Ulrich, Z. Chen, F. G. Wu, Biomaterials 2020, 232, 119668.
- 45J. Shi, P. W. Kantoff, R. Wooster, O. C. Farokhzad, Nat. Rev. Cancer 2017, 17, 20.
- 46S. L. Huang, Adv. Drug Delivery Rev. 2008, 60, 1167.
- 47T. M. Allen, P. R. Cullis, Adv. Drug Delivery Rev. 2013, 65, 36.
- 48B. S. Pattni, V. V. Chupin, V. P. Torchilin, Chem. Rev. 2015, 115, 10938.
- 49U. Bulbake, S. Doppalapudi, N. Kommineni, W. Khan, Pharmaceutics 2017, 9, 12.
- 50Y. Shi, Z. Zhao, K. Peng, Y. Gao, D. Wu, J. Kim, S. Mitragotri, Adv. Healthcare Mater. 2021, 10, 2001455.
